Augmented TLR2 expression on monocytes in both human Kawasaki disease and a mouse model of coronary arteritis

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Lin, I Chun ^a   Kuo, Ho Chang ^a   Lin, Ying Jui ^a   Wang, Feng Shen ^a   Wang, Lin ^a   Huang, Shun Chen ^a   Chien, Shao Ju ^a   Huang, Chien Fu ^a   Wang, Chih Lu ^b   Yu, Hong Ren ^a   Chen, Rong Fu ^c   Yang, Kuender D ^c  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b Po Jen Hospital   (Taiwan)

^c SHOW CHWAN MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; IMMUNOGLOBULIN; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERITIS; ARTICLE; BLOOD SAMPLING; CHILD; CONTROLLED STUDY; CORONARY ARTERITIS; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; ENZYME ACTIVITY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; LACTOBACILLUS CASEI; MAJOR CLINICAL STUDY; MALE; MOUSE; MUCOCUTANEOUS LYMPH NODE SYNDROME; MYOCARDITIS; NONHUMAN; PERICARDITIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TAIWAN; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT OUTCOME;

ANIMALS; ANTIGENS, CD14; CELL WALL; CHILD, PRESCHOOL; CORONARY ARTERY DISEASE; DISEASE MODELS, ANIMAL; FEMALE; GAMMA-GLOBULINS; GENE EXPRESSION REGULATION; HUMANS; INFANT; LACTOBACILLUS CASEI; MALE; MICE; MICE, INBRED BALB C; MONOCYTES; MUCOCUTANEOUS LYMPH NODE SYNDROME; MYOCARDIUM; TOLL-LIKE RECEPTOR 2;

EID: 84862665092     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0038635     Document Type: Article

References (36)

1. Kawasaki T, Kosaki F, Okawa S, Shigematsu I, Yanagawa H, (1974) A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics 54: 271-276.
2. Barron KS, (1998) Kawasaki disease in children. Curr Opin Rheumatol 10: 29-37.
3. Taubert KA, Rowley AH, Shulman ST, (1994) Seven-year national survey of Kawasaki disease and acute rheumatic fever. Pediatr Infect Dis J 13: 704-708.
4. Nakamura Y, Yashiro M, Uehara R, Oki I, Kayaba K, et al. (2008) Increasing incidence of Kawasaki disease in Japan: nationwide survey. Pediatr Int 50: 287-290.
5. Suzuki A, Miyagawa-Tomita S, Komatsu K, Nishikawa T, Sakomura Y, et al. (2000) Active remodeling of the coronary arterial lesions in the late phase of Kawasaki disease: immunohistochemical study. Circulation 101: 2935-2941.
6. Kato H, Sugimura T, Akagi T, Sato N, Hashino K, et al. (1996) Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation 94: 1379-1385.
7. Sugimura T, Kato H, Inoue O, Takagi J, Fukuda T, et al. (1992) Vasodilatory response of the coronary arteries after Kawasaki disease: evaluation by intracoronary injection of isosorbide dinitrate. J Pediatr 121: 684-688.
8. Kato H, Ichinose E, Kawasaki T, (1986) Myocardial infarction in Kawasaki disease: clinical analyses in 195 cases. J Pediatr 108: 923-927.
9. Tsuda E, Arakaki Y, Shimizu T, Sakaguchi H, Yoshimura S, et al. (2005) Changes in causes of sudden deaths by decade in patients with coronary arterial lesions due to Kawasaki disease. Cardiol Young 15: 481-488.
10. Durongpisitkul K, Gururaj VJ, Park JM, Martin CF, (1995) The prevention of coronary artery aneurysm in Kawasaki disease: a meta-analysis on the efficacy of aspirin and immunoglobulin treatment. Pediatrics 96: 1057-1061.
11. Terai M, Shulman ST, (1997) Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose. J Pediatr 131: 888-893.
12. Burns JC, Capparelli EV, Brown JA, Newburger JW, Glode MP, (1998) Intravenous gamma-globulin treatment and retreatment in Kawasaki disease. US/Canadian Kawasaki Syndrome Study Group. Pediatr Infect Dis J 17: 1144-1148.
13. Wallace CA, French JW, Kahn SJ, Sherry DD, (2000) Initial intravenous gammaglobulin treatment failure in Kawasaki disease. Pediatrics 105: E78.
14. Terai M, Jibiki T, Harada A, Terashima Y, Yasukawa K, et al. (1999) Dramatic decrease of circulating levels of monocyte chemoattractant protein-1 in Kawasaki disease after gamma globulin treatment. J Leukoc Biol 65: 566-572.
15. Lin CY, Lin CC, Hwang B, Chiang B, (1992) Serial changes of serum interleukin-6, interleukin-8, and tumor necrosis factor alpha among patients with Kawasaki disease. J Pediatr 121: 924-926.
16. Hirao J, Hibi S, Andoh T, Ichimura T, (1997) High levels of circulating interleukin-4 and interleukin-10 in Kawasaki disease. Int Arch Allergy Immunol 112: 152-156.
17. Kimura J, Takada H, Nomura A, Ohno T, Mizuno Y, et al. (2004) Th1 and Th2 cytokine production is suppressed at the level of transcriptional regulation in Kawasaki disease. Clin Exp Immunol 137: 444-449.
18. Lehman TJ, (1987) Animal models of Kawasaki disease. Prog Clin Biol Res 250: 149-157.
19. Murata H, (1979) Experimental candida-induced arteritis in mice. Relation to arteritis in the mucocutaneous lymph node syndrome. Microbiol Immunol 23: 825-831.
20. Takahashi K, Oharaseki T, Wakayama M, Yokouchi Y, Naoe S, et al. (2004) Histopathological features of murine systemic vasculitis caused by Candida albicans extract-an animal model of Kawasaki disease. Inflamm Res 53: 72-77.
21. Onouchi Z, Ikuta K, Nagamatsu K, Tamiya H, Sakakibara Y, et al. (1995) Coronary artery aneurysms develop in weanling rabbits with serum sickness but not in mature rabbits. An experimental model for Kawasaki disease in humans. Angiology 46: 679-687.
22. Philip S, Lee WC, Liu SK, Wu MH, Lue HC, (2004) A swine model of horse serum-induced coronary vasculitis: an implication for Kawasaki disease. Pediatr Res 55: 211-219.
23. Felsburg PJ, HogenEsch H, Somberg RL, Snyder PW, Glickman LT, (1992) Immunologic abnormalities in canine juvenile polyarteritis syndrome: a naturally occurring animal model of Kawasaki disease. Clin Immunol Immunopathol 65: 110-118.
24. Lehman TJ, Walker SM, Mahnovski V, McCurdy D, (1985) Coronary arteritis in mice following the systemic injection of group B Lactobacillus casei cell walls in aqueous suspension. Arthritis Rheum 28: 652-659.
25. Rosenkranz ME, Schulte DJ, Agle LM, Wong MH, Zhang W, et al. (2005) TLR2 and MyD88 contribute to Lactobacillus casei extract-induced focal coronary arteritis in a mouse model of Kawasaki disease. Circulation 112: 2966-2973.
26. Lin IC, Suen JL, Huang SK, Huang SC, Huang HC,et al. (2012, In press) Dectin-1/Syk signaling is involved in Lactobacillus casei cell wall extract-induced mouse model of Kawasaki disease. Immunobiology.
27. Lehman TJ, Allen JB, Plotz PH, Wilder RL, (1983) Polyarthritis in rats following the systemic injection of Lactobacillus casei cell walls in aqueous suspension. Arthritis Rheum 26: 1259-1265.
28. Haehnel V, Schwarzfischer L, Fenton MJ, Rehli M, (2002) Transcriptional regulation of the human toll-like receptor 2 gene in monocytes and macrophages. J Immunol 168: 5629-5637.
29. Kuo HC, Wang CL, Liang CD, Yu HR, Chen HH, et al. (2007) Persistent monocytosis after intravenous immunoglobulin therapy correlated with the development of coronary artery lesions in patients with Kawasaki disease. J Microbiol Immunol Infect 40: 395-400.
30. Cullen S, Duff DF, Denham B, Ward OC, (1989) Cardiovascular manifestations in Kawasaki disease. Ir J Med Sci 158: 253-256.
31. Fujiwara H, Hamashima Y, (1978) Pathology of the heart in Kawasaki disease. Pediatrics 61: 100-107.
32. Suzuki A, Kamiya T, Tsuchiya K, Sato I, Arakaki Y, et al. (1988) Tricuspid and mitral regurgitation detected by color flow Doppler in the acute phase of Kawasaki disease. Am J Cardiol 61: 386-390.
33. Schulte DJ, Yilmaz A, Shimada K, Fishbein MC, Lowe EL, et al. (2009) Involvement of innate and adaptive immunity in a murine model of coronary arteritis mimicking Kawasaki disease. J Immunol 183: 5311-5318.
34. Kuo HC, Yang KD, Juo SH, Liang CD, Chen WC, et al. (2011) ITPKC single nucleotide polymorphism associated with the Kawasaki disease in a Taiwanese population. PLoS One 6: e17370.
35. Kuo HC, Yang KD, Liang CD, Bong CN, Yu HR, et al. (2007) The relationship of eosinophilia to intravenous immunoglobulin treatment failure in Kawasaki disease. Pediatr Allergy Immunol 18: 354-359.
36. Dubois M, Gilles K, Hamilton JK, Rebers PA, Smith F, (1956) Colorimetric method for the determination of sugars and related substances. Anal Chem 28: 350-356.